BIOMAT Database Logo BIOMAT Database Logo

Preconditioning of bone marrow mesenchymal stem cells with hydrogen sulfide improves their therapeutic potential. 2016

Qun Zhang, and Song Liu, and Tong Li, and Lin Yuan, and Hansen Liu, and Xueer Wang, and Fuwu Wang, and Shuanglian Wang, and Aijun Hao, and Dexiang Liu, and Zhen Wang
Department of Physiology, Shandong University School of Medicine, Jinan, Shandong 250012, P.R. China.

Bone marrow mesenchymal stem cells (BMSCs) transplantation has shown great promises for treating various brain diseases. However, poor viability of transplanted BMSCs in injured brain has limited the therapeutic efficiency. Hypoxia-ischemic injury is one of major mechanisms underlying the survival of transplanted BMSCs. We investigated the mechanism of preconditioning of BMSCs with hydrogen sulfide (H2S), which has been proposed as a novel therapeutic strategy for hypoxia-ischemic injury. In this study, we demonstrated that preconditioning of NaHS, a H2S donor, effectively suppressed hypoxia-ischemic-induced apoptosis whereby the rise in Bax/Bcl-2 ratio. Further analyses revealed Akt and ERK1/2 pathways were involved in the protective effects of NaHS. In addition, NaHS preconditioning increased secretion of BDNF and VEGF in BMSCs. Consistent with in vitro data, transplantation of NaHS preconditioned BMSCs in vivo further enhanced the therapeutic effects of BMSCs on neuronal injury and neurological recovery, associated with increased vessel density and upregulation of BDNF and VEGF in the ischemic tissue. These findings suggest that H2S could enhance the therapeutic effects of BMSCs. The underlying mechanisms might be due to enhanced capacity of BMSCs and upregulation of protective cytokines in the hypoxia tissue.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D008297 Male Males
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D001927 Brain Diseases Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. Intracranial Central Nervous System Disorders,Brain Disorders,CNS Disorders, Intracranial,Central Nervous System Disorders, Intracranial,Central Nervous System Intracranial Disorders,Encephalon Diseases,Encephalopathy,Intracranial CNS Disorders,Brain Disease,Brain Disorder,CNS Disorder, Intracranial,Encephalon Disease,Encephalopathies,Intracranial CNS Disorder
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006862 Hydrogen Sulfide A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed) Hydrogen Sulfide (H2(Sx)),Hydrogen Sulfide (H2S2),Hydrogen Sulfide (H2S3),Sulfide, Hydrogen
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies

Related Publications

Qun Zhang, and Song Liu, and Tong Li, and Lin Yuan, and Hansen Liu, and Xueer Wang, and Fuwu Wang, and Shuanglian Wang, and Aijun Hao, and Dexiang Liu, and Zhen Wang
Hypoxic Preconditioning Improves the Therapeutic Potential of Aging Bone Marrow Mesenchymal Stem Cells in Streptozotocin-Induced Type-1 Diabetic Mice.
October 2016, Cellular reprogramming,
Qun Zhang, and Song Liu, and Tong Li, and Lin Yuan, and Hansen Liu, and Xueer Wang, and Fuwu Wang, and Shuanglian Wang, and Aijun Hao, and Dexiang Liu, and Zhen Wang
Integral therapeutic potential of bone marrow mesenchymal stem cells.
February 2005, Current drug targets,
Qun Zhang, and Song Liu, and Tong Li, and Lin Yuan, and Hansen Liu, and Xueer Wang, and Fuwu Wang, and Shuanglian Wang, and Aijun Hao, and Dexiang Liu, and Zhen Wang
Preconditioning of mesenchymal stem cells by sevoflurane to improve their therapeutic potential.
January 2014, PloS one,
Qun Zhang, and Song Liu, and Tong Li, and Lin Yuan, and Hansen Liu, and Xueer Wang, and Fuwu Wang, and Shuanglian Wang, and Aijun Hao, and Dexiang Liu, and Zhen Wang
Preconditioning with melatonin improves therapeutic outcomes of bone marrow-derived mesenchymal stem cells in targeting liver fibrosis induced by CCl4.
August 2017, Cell and tissue research,
Qun Zhang, and Song Liu, and Tong Li, and Lin Yuan, and Hansen Liu, and Xueer Wang, and Fuwu Wang, and Shuanglian Wang, and Aijun Hao, and Dexiang Liu, and Zhen Wang
Bone marrow-derived liver stem cells: their therapeutic potential.
August 2002, Gastroenterology,
Qun Zhang, and Song Liu, and Tong Li, and Lin Yuan, and Hansen Liu, and Xueer Wang, and Fuwu Wang, and Shuanglian Wang, and Aijun Hao, and Dexiang Liu, and Zhen Wang
Therapeutic potential of bone marrow mesenchymal stem cells in cyclophosphamide-induced infertility.
January 2023, Frontiers in pharmacology,
Qun Zhang, and Song Liu, and Tong Li, and Lin Yuan, and Hansen Liu, and Xueer Wang, and Fuwu Wang, and Shuanglian Wang, and Aijun Hao, and Dexiang Liu, and Zhen Wang
Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization.
October 2018, Stem cell research & therapy,
Qun Zhang, and Song Liu, and Tong Li, and Lin Yuan, and Hansen Liu, and Xueer Wang, and Fuwu Wang, and Shuanglian Wang, and Aijun Hao, and Dexiang Liu, and Zhen Wang
Odontogenic potential of bone marrow mesenchymal stem cells.
March 2007, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons,
Qun Zhang, and Song Liu, and Tong Li, and Lin Yuan, and Hansen Liu, and Xueer Wang, and Fuwu Wang, and Shuanglian Wang, and Aijun Hao, and Dexiang Liu, and Zhen Wang
Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.
April 2016, Cytotherapy,
Qun Zhang, and Song Liu, and Tong Li, and Lin Yuan, and Hansen Liu, and Xueer Wang, and Fuwu Wang, and Shuanglian Wang, and Aijun Hao, and Dexiang Liu, and Zhen Wang
Zinc and hypoxic preconditioning: a strategy to enhance the functionality and therapeutic potential of bone marrow-derived mesenchymal stem cells.
December 2022, Molecular and cellular biochemistry,
Copied contents to your clipboard!